Tirzepatide Calculator & Guide

Last updated: March 2026

Mounjaro & Zepbound • Dual GIP/GLP-1 Receptor Agonist • Weight Loss & Diabetes

🧮 Interactive Dose Calculator

Injection Volume:
0.5mL (50 units)
Concentration: 2.5mg/mL

📑 Table of Contents

⚠️ Research Purposes Only: Tirzepatide is available by prescription as Mounjaro and Zepbound. Research peptides are not FDA-approved for human use. This guide is for educational purposes. Consult a healthcare provider before use.

What is Tirzepatide?

Tirzepatide is a revolutionary dual receptor agonist that targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This unique dual mechanism makes it highly effective for both diabetes management and weight loss.

Key Mechanisms of Action

  • GLP-1 activation: Slows gastric emptying, increases satiety, improves glucose control
  • GIP activation: Enhances insulin sensitivity, promotes fat utilization
  • Appetite suppression: Reduces food cravings and portion sizes
  • Metabolic enhancement: Improves insulin sensitivity and glucose metabolism
🎯 Clinical Success: SURMOUNT-1 trial showed an average 21% body weight reduction at the highest dose (15mg weekly) - the most effective weight loss medication ever tested in clinical trials.

Clinical Trial Results

SURMOUNT-1 (Weight Loss in Non-Diabetics)

The landmark SURMOUNT-1 study followed 2,539 participants for 72 weeks, demonstrating unprecedented weight loss results:

Dose Average Weight Loss ≥20% Weight Loss ≥25% Weight Loss
5mg weekly 16.0% 32% 16%
10mg weekly 21.4% 55% 36%
15mg weekly 22.5% 57% 40%
Placebo 2.4% 2% 1%

SURPASS Series (Diabetes)

Multiple SURPASS trials demonstrated superior glycemic control compared to other diabetes medications, with significant weight loss as a bonus benefit.

FDA Approvals

  • May 2022: Mounjaro approved for Type 2 diabetes
  • November 2023: Zepbound approved for weight management
  • Both approvals based on extensive Phase 3 clinical trial data
  • Fastest FDA review for an obesity medication in history

Dosing Protocol & Schedule

Tirzepatide follows a gradual dose escalation schedule to minimize side effects and maximize tolerance. The protocol is the same whether used for diabetes (Mounjaro) or weight loss (Zepbound).

Weeks Dose Purpose Expected Effects
1-4 2.5mg weekly Initial tolerance Mild appetite reduction, minimal side effects
5-8 5mg weekly First therapeutic dose Noticeable appetite suppression, early weight loss
9-12 7.5mg weekly Intermediate escalation Significant weight loss, improved satiety
13-16 10mg weekly Higher therapeutic dose Substantial weight loss, metabolic improvements
17-20 12.5mg weekly Pre-maximum dose Near-maximum benefits
21+ 15mg weekly Maximum dose Peak weight loss and metabolic benefits

Dosing Guidelines

  • Weekly injection: Same day each week, any time of day
  • Injection sites: Rotate between abdomen, thigh, and upper arm
  • Dose timing: Can be taken with or without food
  • Missed dose: Take within 4 days, otherwise skip and resume schedule
  • Maintenance: Many patients find their optimal dose between 10-15mg

How to Reconstitute Tirzepatide

Research tirzepatide typically comes as lyophilized powder in various vial sizes. Proper reconstitution is critical for maintaining potency.

Common Vial Sizes & Reconstitution

5mg Vial Reconstitution Options

  • 2mL bacteriostatic water: 2.5mg/mL concentration
  • 1mL bacteriostatic water: 5mg/mL concentration (more potent)
  • 2mL provides easier dosing for lower doses (2.5mg-7.5mg range)

10mg Vial Reconstitution Options

  • 2mL bacteriostatic water: 5mg/mL concentration
  • 4mL bacteriostatic water: 2.5mg/mL concentration
  • Most versatile option for all dose ranges

30mg Vial Reconstitution (Advanced)

  • 3mL bacteriostatic water: 10mg/mL concentration
  • 6mL bacteriostatic water: 5mg/mL concentration
  • Best value but requires precise dosing

Reconstitution Steps

  1. Remove caps from both vials (peptide and bacteriostatic water)
  2. Wipe rubber stoppers with alcohol pads
  3. Draw desired amount of bacteriostatic water into syringe
  4. Insert needle into peptide vial at 45° angle
  5. Slowly inject water down the side of vial (not directly onto powder)
  6. Gently swirl (never shake) to dissolve completely
  7. Solution should be clear - discard if cloudy or contains particles

🧮 Need Different Concentrations?

Use the calculator above to find your exact injection volume for any vial size and dose combination.

Advanced Calculator →

Tirzepatide vs Semaglutide vs Retatrutide

Feature Tirzepatide Semaglutide Retatrutide
Mechanism Dual GIP/GLP-1 agonist GLP-1 agonist only Triple GLP-1/GIP/Glucagon agonist
Weight Loss (avg) 21% (15mg dose) 15% (2.4mg dose) 24% (12mg dose)
Dosing Frequency Weekly Weekly Weekly
FDA Status Approved (diabetes & weight loss) Approved (diabetes & weight loss) Phase 3 trials
Brand Names Mounjaro, Zepbound Ozempic, Wegovy Not yet available
Side Effect Profile Moderate GI effects Higher GI side effects Similar to tirzepatide
Glucose Control Superior (dual mechanism) Excellent Excellent
Research Availability Widely available Widely available Limited availability
🏆 Why Tirzepatide Often Wins: The dual GIP/GLP-1 mechanism provides superior weight loss compared to semaglutide, with potentially better tolerance than retatrutide. It's the "sweet spot" of current GLP-1 medications.

Side Effects & Management

Like all GLP-1 medications, tirzepatide can cause side effects, particularly gastrointestinal symptoms. Most are dose-dependent and improve with time.

Common Side Effects (>5% of patients)

  • Nausea: Most common, especially during dose escalation
  • Diarrhea: Often transient, improves with continued use
  • Reduced appetite: Desired effect that can be dramatic
  • Vomiting: More common with rapid dose increases
  • Injection site reactions: Redness, swelling, or irritation
  • Fatigue: Often related to rapid dietary changes
  • Constipation: Can alternate with diarrhea

Side Effect Management Strategies

For Nausea & GI Issues:

  • Take injection before bed to sleep through initial nausea
  • Eat smaller, more frequent meals
  • Avoid high-fat, high-sugar foods
  • Stay hydrated with clear fluids
  • Consider ginger tea or supplements
  • Slow dose escalation if side effects are severe
⚠️ Serious Side Effects (Rare):
  • Pancreatitis (severe abdominal pain)
  • Gallbladder problems
  • Severe dehydration from vomiting/diarrhea
  • Thyroid C-cell tumors (animal studies only)
  • Severe hypoglycemia (if used with insulin/sulfonylureas)
Seek immediate medical attention for severe abdominal pain, persistent vomiting, or signs of pancreatitis.

Storage Guidelines

Form Storage Conditions Shelf Life Notes
Lyophilized powder Room temp or refrigerated 2+ years Most stable form
Reconstituted (in use) Refrigerated (36-46°F) 4-6 weeks Use bacteriostatic water
Reconstituted (unused) Frozen (-4°F) 6+ months Single-use portions
Prefilled pens (Rx) Refrigerated until first use 21-30 days at room temp Never freeze pens

Storage Best Practices

  • Protect from light: Store in original packaging or wrap in foil
  • Avoid temperature extremes: Never freeze reconstituted peptides
  • Use bacteriostatic water: Contains preservatives for longer shelf life
  • Single-use syringes: Draw only what you need to prevent contamination
  • Monitor for changes: Discard if solution becomes cloudy or discolored

Brand Names & Availability

Prescription Brands

Mounjaro (Diabetes)

  • Indication: Type 2 diabetes
  • Doses: 2.5, 5, 7.5, 10, 12.5, 15mg prefilled pens
  • Insurance: Often covered for diabetes
  • Cost: $900-1,000/month without insurance

Zepbound (Weight Loss)

  • Indication: Chronic weight management
  • Same doses: Identical to Mounjaro
  • Insurance: Limited coverage for obesity
  • Patient assistance: Savings programs available

Research Peptides

Tirzepatide is available from research peptide vendors labeled "for research purposes only." Quality varies significantly between suppliers.

What to Look for in Research Peptides:

  • Third-party testing: COA (Certificate of Analysis) with purity >98%
  • HPLC testing: Confirms identity and purity
  • Proper packaging: Sealed vials, appropriate labeling
  • Vendor reputation: Established suppliers with good reviews
  • Storage handling: Cold chain shipping, proper storage

Frequently Asked Questions

How quickly will I see weight loss results?

Most patients notice appetite reduction within the first week. Significant weight loss typically begins around week 4-8, with peak effects at 15-20 weeks. In clinical trials, patients lost an average of 5-10% of body weight by week 20.

Can I stay at a lower dose if it's working?

Yes! Many patients find their "sweet spot" between 5-10mg weekly. The goal is the lowest effective dose that provides desired weight loss with tolerable side effects. Some patients maintain excellent results on 7.5mg weekly.

What happens if I stop taking tirzepatide?

Weight regain is common but not inevitable. The SURMOUNT-1 study showed participants regained about 7% of lost weight one year after stopping. Lifestyle modifications become crucial for long-term maintenance.

Can I use tirzepatide if I don't have diabetes?

Zepbound is FDA-approved for weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition. Consult with a healthcare provider to determine if you're a candidate.

How does tirzepatide compare to bariatric surgery?

Tirzepatide produces weight loss comparable to some bariatric procedures (15-22% vs 20-30% for surgery) but is reversible and has fewer risks. It's often considered for patients who don't qualify for or want to avoid surgery.

Are there any drug interactions?

Tirzepatide can slow gastric emptying, potentially affecting oral medication absorption. It may enhance the blood sugar-lowering effects of insulin or sulfonylureas, requiring dose adjustments. Always inform healthcare providers of all medications.

Is tirzepatide safe during pregnancy?

No. Tirzepatide should be discontinued at least 2 months before planned pregnancy. It's not recommended during pregnancy or breastfeeding. Weight loss during pregnancy can harm fetal development.

🔬 Ready to Calculate Your Protocol?

Use our advanced calculator to plan your complete tirzepatide dosing schedule and track your progress.

Full Calculator →

💊 Compare Other Weight Loss Peptides

Explore semaglutide, retatrutide, and other weight loss peptides to find your optimal protocol.

Browse Peptides →

📚 References

  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. PubMed
  2. Rosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021;398(10295):143-155. PubMed
  3. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. PubMed
  4. Del Prato S, Kahn SE, Pavo I, et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet. 2021;398(10313):1811-1824. PubMed